2014
DOI: 10.1097/scs.0000000000000510
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic Orbital Myositis

Abstract: Orbital myositis occurs in multiple clinical manifestations and may be recurrent. Imaging is an important technique for use in diagnosis. Systemic corticosteroid represents an effective approach for treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
41
0
5

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(46 citation statements)
references
References 19 publications
0
41
0
5
Order By: Relevance
“…The most commonly used criteria for the classification of IIMs are those that were proposed by Bohan and Peter in 1975 [1]. From a clinico-pathological perspective, the IIMs fall into six categories: (1) dermatomyositis (DM; juvenile, adult), (2) polymyositis (PM; T-cell mediated, eosinophilic, granulomatous), (3) overlap syndromes (with DM, with PM, with sIBM/hIBM), (4) cancer-associated myositis, (5) inclusion body myositis (IBM), and (6) other forms (focal: orbital myositis, localised nodular myositis, inflammatory pseudotumor; diffuse: macrophagic myofasciitis, necrotizing autoimmune myopathy (NAM), infantile myositis) [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]. Although this clinico-pathological subdivision has a predictive value in prognosis and in therapy, according to our rising knowledge of the autoantibodies, this system seems to be worn out.…”
Section: Introductionmentioning
confidence: 99%
“…The most commonly used criteria for the classification of IIMs are those that were proposed by Bohan and Peter in 1975 [1]. From a clinico-pathological perspective, the IIMs fall into six categories: (1) dermatomyositis (DM; juvenile, adult), (2) polymyositis (PM; T-cell mediated, eosinophilic, granulomatous), (3) overlap syndromes (with DM, with PM, with sIBM/hIBM), (4) cancer-associated myositis, (5) inclusion body myositis (IBM), and (6) other forms (focal: orbital myositis, localised nodular myositis, inflammatory pseudotumor; diffuse: macrophagic myofasciitis, necrotizing autoimmune myopathy (NAM), infantile myositis) [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]. Although this clinico-pathological subdivision has a predictive value in prognosis and in therapy, according to our rising knowledge of the autoantibodies, this system seems to be worn out.…”
Section: Introductionmentioning
confidence: 99%
“…Idiopathic orbital myositis is usually diagnosed clinically based on the exclusion of other inflammatory or neoplastic diseases involving extraocular muscles. [1][2][3][4][5][6][7][8][9][10][11] Excisional or needle biopsy of the extraocular muscle is usually not performed because of the difficulty in approaching thin extraocular muscles which pass in close contact with the eye globe along the anteroposterior curvature. Thus, therapeutic diagnosis with oral corticosteroids still remains to be the standard at the setting of clinical ophthalmology.…”
Section: Discussionmentioning
confidence: 99%
“…NSOİ'nin tedavisinde sistemik steroidler (oral prednizolon) 1 mg/kg /gün tedavide ilk basamak olarak kullanılmaktadır (2). Fakat bazı yazarlara göre tek bir ekstraoküler kas tutulumu gözlem-lendiğinde ilk olarak düşük doz oral steroidleri (20 mg/ gün prednizolon) ya da nonsteroid antiinflamatuvar ilaç-ları önermektedir (12). Eğer birden çok ekstraoküler kas tutulumu görüldüğünde yüksek doz steroid (40-60 mg/ gün prednizolon) tedavisi önermektedir (12).…”
Section: Discussionunclassified
“…Fakat bazı yazarlara göre tek bir ekstraoküler kas tutulumu gözlem-lendiğinde ilk olarak düşük doz oral steroidleri (20 mg/ gün prednizolon) ya da nonsteroid antiinflamatuvar ilaç-ları önermektedir (12). Eğer birden çok ekstraoküler kas tutulumu görüldüğünde yüksek doz steroid (40-60 mg/ gün prednizolon) tedavisi önermektedir (12). İdiyopatik orbital miyozitte kortikosteroidlere hızlı ve oldukça iyi yanıt olmasına rağmen, rekürrens olasılığı nedeniyle steroid tedavisinin 4-6 hafta devam edilmesi ve yavaş yavaş azaltılarak kesilmesi önerilmektedir.…”
Section: Discussionunclassified